Last Updated: May 10, 2026

List of Excipients in API brivaracetam


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing brivaracetam

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
UCB Inc BRIVIACT brivaracetam 50474-370 ANHYDROUS LACTOSE
UCB Inc BRIVIACT brivaracetam 50474-370 BETADEX
UCB Inc BRIVIACT brivaracetam 50474-370 CROSCARMELLOSE SODIUM
UCB Inc BRIVIACT brivaracetam 50474-370 LACTOSE MONOHYDRATE
UCB Inc BRIVIACT brivaracetam 50474-370 MAGNESIUM STEARATE
UCB Inc BRIVIACT brivaracetam 50474-370 POLYETHYLENE GLYCOL 3350
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Start Trial

Excipients in ANDA-approved (generic) drugs containing brivaracetam

Company Ingredient NDC Excipient
PAI Holdings LLC dba PAI Pharma brivaracetam 0121-1074 CARBOXYMETHYLCELLULOSE SODIUM
PAI Holdings LLC dba PAI Pharma brivaracetam 0121-1074 CITRIC ACID
PAI Holdings LLC dba PAI Pharma brivaracetam 0121-1074 GLYCERIN
PAI Holdings LLC dba PAI Pharma brivaracetam 0121-1074 METHYLPARABEN
PAI Holdings LLC dba PAI Pharma brivaracetam 0121-1074 SODIUM CITRATE
PAI Holdings LLC dba PAI Pharma brivaracetam 0121-1074 SORBITOL SOLUTION
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Start Trial

Detailed excipient profiles for brivaracetam

Excipient focus: ACETIC ACID

Excipient focus: ANHYDROUS CITRIC ACID

Excipient focus: ANHYDROUS LACTOSE

Excipient focus: BETADEX

Excipient focus: CARBOXYMETHYLCELLULOSE SODIUM

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: CITRIC ACID

Excipient focus: CROSCARMELLOSE SODIUM

Excipient focus: FERRIC OXIDE RED

Excipient focus: FERRIC OXIDE YELLOW

Excipient focus: GLYCERIN

Excipient focus: GLYCERYL MONO AND DICAPRYLOCAPRATE

Excipient focus: GLYCERYL MONO- AND DICAPRYLOCAPRATE

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: MAGNESIUM STEARATE

Excipient focus: MALTODEXTRIN

Excipient focus: METHYLPARABEN

Excipient focus: METHYLPARABEN SODIUM

Excipient focus: NONCRYSTALLIZING SORBITOL SOLUTION

Excipient focus: POLYETHYLENE GLYCOL

Excipient focus: POLYETHYLENE GLYCOL 3350

Excipient focus: POLYVINYL ALCOHOL

Excipient focus: PROPYLENE GLYCOL

Excipient focus: SODIUM ACETATE

Excipient focus: SODIUM CHLORIDE

Excipient focus: SODIUM CITRATE

Excipient focus: SODIUM LAURYL SULFATE

Excipient focus: SORBITOL

Excipient focus: SORBITOL SOLUTION

Excipient focus: SUCRALOSE

Excipient focus: TALC

Excipient focus: TITANIUM DIOXIDE

Excipient focus: TRISODIUM CITRATE DIHYDRATE

Excipient focus: WATER

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2026 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2026 - 2027
 NCE-1 Patent Challenge Dates 2026 - 2027
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links